Affiliation:
1. Laboratoire de Microbiologie, Faculté de Pharmacie, Centre d'Etudes Pharmaceutiques, Châtenay-Malabry, France.
Abstract
In an attempt to understand more completely why patients treated with phenothiazines (chlorpromazine and cyamemazine), methotrexate, and certain antibiotics such as clindamycin have an increased risk of developing pseudomembranous colitis, the production of toxins A and B by Clostridium difficile in the presence of these drugs was measured in vitro as well as in vivo by using axenic mice. None of the drugs tested increased the production of toxins either in vitro or in vivo.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference32 articles.
1. Antimicrobial agents and Clostridium difficile in acute enteric disease;Aronsson B.;J. Infect. Dis.,1985
2. La flore colique normale et ses fonctions;Audiger J. C.;Rev. Prat.,1982
3. Antimicrobial agents implicated in Clostridium difficile toxin associated diarrhea or colitis;Bartlett J. G.;Johns Hopkins Med. J.,1981
4. Treatment of antibiotic associated pseudomembranous colitis;Bartlett J. G.;Rev. Infect. Dis.,1984
5. Role of Clostridium difficile in antibiotic associated pseudomembranous colitis;Bartlett J. G.;Gastroenterology,1978
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献